APA Style

Miah, D, M, H. (2018). Treatment outcome of combination therapy of sofosbuvir and daclatasvir for 12 weeks versus combination of sofosbuvir and ribavirin for 24 weeks in HCV Genotype 3 chronic hepatitis patients . BSMMU: Dr. Md. Humayan Miah.

MLA Style

Miah, Dr., Md., Humayan. "Treatment outcome of combination therapy of sofosbuvir and daclatasvir for 12 weeks versus combination of sofosbuvir and ribavirin for 24 weeks in HCV Genotype 3 chronic hepatitis patients". BSMMU: Dr. Md. Humayan Miah, 2018. Thesis.